- The growing number of multi-drug resistant bacterial strains is one key factor driving the global antibacterial drugs market.
- The global antibacterial drugs market was valued $26.4 Bn in 2017 and is expected to reach $34.2 Bn by 2026, at a CAGR of 3.29 % during the forecast period.
- Cell wall biosynthesis inhibitors (CBIs) is one of the most effective mechanism of antibiotics and the most extensively used class of antibiotics.
An increasingly older population, rising demand for efficient and affordable antibacterial drugs and the growing number of multi-drug resistant bacterial strains are some of the key factors which are driving the global antibacterial drugs market.
The global antibacterial drugs market was valued $26.4 Bn in 2017 and is expected to reach $34.2 Bn by 2026, at a CAGR of 3.29 % during the forecast period.
High prevalence of infectious diseases, increased research and development activities, product differentiation through various methods, and rise government support are boosting market growth. The rising number of product approvals and subsequent launch of the products are the main factors expected to boost growth of the market over the forecast period. Reduced time for action and fewer side effects are projected to offer a good opportunity for growth of the antibacterial drugs market. However, the rise in drug-resistant species, launching of generic drugs, and patent expiry are limiting market growth.
Retail pharmacies segment accounts for a major revenue share of the global antibacterial drugs market owing to their providing advice about health issues, symptoms & medications in response to customer inquiries, recruiting, training & managing staff, and treating prescriptions & dispensing medication.
Penicillin is a group of antibiotics, which contain penicillin G, penicillin V, procaine penicillin, and benzathine penicillin. Penicillin antibiotics are among the first medications to be effective against many bacterial infections caused by staphylococci and streptococci.
The cephalosporins are a class of β-lactam antibiotics, which is originally derived from the fungus Acremonium. Cephalosporins drugs are used to treat bacterial infections including ear & skin infections, pneumonia, kidney & bone infections, sexually transmitted infections such as gonorrhoea, and strep throat & other throat infections.
Cell wall biosynthesis inhibitors (CBIs) is one of the most effective mechanism of antibiotics and the most extensively used class of antibiotics. However, this mechanism of antibiotics is not received without impunity from resistance development.
Buy Research Report: Radiology Information Systems Market to Witness A Steep CAGR Of 8.3%
Buy Research Report: Mobile Water Treatment Systems Market Set to Grow US$ 1,952.0 Mn during 2020-2030
Buy Research Report: Electric Trolling Motors Market to Expand at a CAGR of 3.2% During 2020-2030
Buy Research Report: Global Solar Cells and Modules Market Strategic Assessment and Forecast by 2026
Buy Research Report: What Are the Upcoming Trends in the Telemonitoring System Market? What Impact Would They Make in Forecast – 2026?
North America is leading the global antibacterial drugs market in terms of revenue due to the presence of significant market players in the region. Europe accounts for the second-largest revenue share in the global antibacterial drugs market, followed by Asia Pacific, South America, and the Middle East & Africa respectively. The Asia Pacific region is expected to register comparatively faster growth in terms of revenue during the forecast period due to the increasing healthcare infrastructure and the growing prevalence of bacterial infections.
Global Antibacterial Drugs Market, by Drug Class: Penicillins, Cephalosporins, Quinolone, Aminoglycosides, Monobactams, Carbapenems, Macrolides, and Other Drug Class. Global Antibacterial Drugs Market, by Drug Mechanism:Cell Wall Synthesis inhibitors, Protein Synthesis inhibitors, Nucleic Acid inhibitors, Folic Acid synthesis inhibitors, and Mycolic Acid synthesis inhibitors. Global Antibacterial Drugs Market, by Route of Administration: Oral, Topical, Parenteral, and Other Route of Administration. Global Antibacterial Drugs Market, by Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Sales,.
Global Antibacterial Drugs Market, by Region: North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Key Player Operating In the Global Antibacterial Drugs Market: Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc., Novartis AG, Eli Lilly & Company, Johnson & Johnson, Sanofi, AstraZeneca plc., Bayer AG, Abbott Laboratories, Daiichi Sankyo Company, Takeda Pharmaceutical Company Ltd, Bristol Myers Squibb Company, and Allergen Plc.